Global Pneumonia Vaccines Market Size, Share, Trend, Forecast, & Industry Analysis: 2020-2025
See less
Global Pneumonia Vaccines Market Size, Share, Trend, Forecast, & Industry Analysis: 2020-2025
... See more
The Pneumonia Vaccines Market is Segmented by Product Type (Pneumonia Conjugate Vaccines, Pneumonia Polysaccharide Vaccines) and by Region (North America, Europe, Asia-Pacific, and the Rest of the World)
The Pneumonia Vaccines Market is Segmented by Product Type (Pneumonia Conjugate Vaccines, Pneumonia Polysaccharide Vaccines) and by Region (North America, Europe, Asia-Pacific, and the Rest of the World)
...
Pneumonia is a disease that causes lung contamination by a bacterial or viral infection of the air sacs in one or both of the lungs and is commonly found in adults.
Global Pneumonia Vaccines Market Report Overview
Market Size in 2025
USD X.XX Billion
Market Size in 2020
USD X.XX Billion
Market Growth (2020-2025)
CAGR of 5.0%
Base Year of Study
2019
Trend Period
2015-2018
Forecast Period
2020-2025
Market Drivers
The growing prevalence of chronic diseases such as chronic obstructive pulmonary disease, diabetes mellitus, and chronic heart disease, pneumococcal contamination within the population, the introduction of novel pneumococcal vaccine
Increasing support of the government in creating awareness about pneumonia immunization programs is one of the major factors accelerating the growth of the market during the forecast period.
The market is segmented into pneumonia conjugate vaccines and pneumonia polysaccharide vaccines. The pneumonia conjugate vaccine is estimated to be the largest product type in the market owing to its ability to immunize infants and children from the age of 6 weeks to 5 years, providing prevention from invasive disease, pneumonia, and acute otitis media.
There has been an increase in the adoption and usage of pneumonia conjugate vaccines amongst the population as many people are vulnerable to pneumonia including children below 5 years and adults above 50 years as well.
On the contrary, the pneumonia polysaccharide vaccine is estimated to be the fastest-growing segment in the market. The growth is attributed to the Pneumovax 23 which has been proven very effective in protecting healthy young adults from invasive pneumonia disease, fueling the product demand during the forecast period.
By Region
Asia-Pacific is leading the market with India being the major country witnessing a significant growth rate, attributed to the increasing prevalence of pneumonia and growing mortality associated with the disease which is expected to fuel the product demand during the forecast period.
Further, the government getting strong funds from the Global Alliance of Vaccines and Immunization for more accessible pneumonia vaccines and increasing affordability will accelerate the growth of the regional market over the forecast period. North America and Europe are also expected to offer substantial growth opportunities during the forecast period.
To get more information about this report, register here.
Segmentation
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.
The market is segmented into the following categories.
By Product Type:
Pneumonia Conjugate Vaccines
Pneumonia Saccharide Vaccines
By Region:
North America (Country Analysis: the USA, Canada, and Mexico)
Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)
To understand more about this segment trend, register here.
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.
We conducted more than 10 detailed primary interviews with companies across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.
Report Features
This report provides intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the dynamics and will enable strategic decision-making for the existing players as well as those willing to enter the market.
What Deliverables Will You Get in this Report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
in-depth analysis of the pneumonia vaccines market
How lucrative is the future?
The market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional, and country-level historical data and forecasts
Which are the most attractive market segments?
Market Segment Analysis and Forecast
What are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirements?
10% free customization
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to 3 players)
SWOT analysis of key players (up to 3 players)
Market Segmentation
Current market segmentation of any one of the product types by region type.
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
Pneumonia is a disease that causes lung contamination by a bacterial or viral infection of the air sacs in one or both of the lungs, and is commonly found in adults.
GlaxoSmithKline Plc., LG Chem Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Bioscience, and Walvax Biotechnology Co., Ltd are among the key players in the pneumonia vaccine market.
The growing prevalence of chronic diseases such as chronic obstructive pulmonary disease, diabetes mellitus and chronic heart disease, pneumococcal contamination within the population, the introduction of novel pneumococcal vaccine
Increasing support of the government in creating awareness about pneumonia immunization programs is some of the major factors accelerating the growth of the market during the forecast period.